BioWorld-Insight-2002-02-18
Money Raised Year To Date
Biologics Manufacturing Logjam: Can The Industry Meet Demands?
"Logjam" and "bottleneck" became popular words as the industry entered what became called the "post-genomic era" (and grew into yet another oft-used phrase). But everybody was talking about data, not drugs and that, of course, became the problem. While there was plenty of information, not much in the way of new treatments was coming out of it quickly. (BioWorld Financial Watch)
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: January 2002
No Abstract

